Radiotherapy and the role of the immune system

Authors

  • Oscar Sotolongo Grau Departamento de Física Matemática y Fluidos. Universidad Nacional de Educación a Distancia, Madrid
  • Daniel Rodríguez Pérez Departamento de Física Matemática y Fluidos. Universidad Nacional de Educación a Distancia, Madrid
  • J. C. Antoranz Departamento de Física Matemática y Fluidos. Universidad Nacional de Educación a Distancia, Madrid
  • Luis M. Gaggero Sager Departamento de Física. Universidad Autónoma del Estado de Morelos
  • Oscar Sotolongo Costa Cátedra de Sistemas Complejos “Henri Poincaré”. Universidad de La Habana

DOI:

https://doi.org/10.21640/ns.v4i8.165

Keywords:

DynamicalSystems, Radiobiology

Abstract

Using a population dynamics formulation to model radiotherapy treatments a large amount of patients under treatment was mimicked. From the obtained results a method to change the number of radiation sessions while keeping the optimized treatment is found. Also a power law relating immune system - tumor effciency ratio (ISTER) for a given patient and maximum success probability of radiotherapy treatment is obtained.

Downloads

Download data is not yet available.

References

O Sotolongo-Grau, D Rodriguez Perez, JA Santos Miranda, O Sotolongo- Costa, and JC Antoranz. Immune system-tumour effciency ratio as a new oncological index for radiotherapy treatment optimization. Math Med Biol, page dqp005, 2009.

VA Kuznetsov, I Makalkin, MA Taylor, and AS Perelson. Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. Bull Math Biology, 56: 295-321, 1994.

A d'Onofrio. A general framework for modeling tumor-inmune system competition and immunotherapy: Mathematical analysis and biomedical inferences. Physica D, 208:220-235, 2005.

A Matzavinos, M Chaplain, and V Kuznetsov. Mathematical modelling of the spatio-temporal response of cytotoxic t-lymphocytes to a solid tumour. Math Med Biol, 21:1-34, 2004.

A Matzavinos and M Chaplain. Travelling wave analysis of a model of the immune response to cancer. C. R. Biologies, 327:995-1008, 2004.

RK Sachs and LR Hlatky. Simple ode models of tumor growth and antiangiogenic or radiation treatment. Math. Comp. Modelling, 33:1297-1305, 2001.

D Kirschner and J Panetta. Modelling immunotherapy of the tumor-immune system interaction. J. Math. Biol., 38:235-252, 1998.

L de Pillis, AE Radunskaya, and CL Wiseman. A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Research, 65:7950-7958, 2005.

O Sotolongo-Costa and et al. Behavior of tumors under nonstationary therapy. Physica D, 178:242-253, 2003.

Galach M. Dynamics of the tumor-immune system competition - the effect of time delay. Int J Appl Math Comput Sci, 13:395-406, 2003.

D Rodriguez-Perez, O Sotolongo-Grau, R Espinosa Riquelme, O Sotolongo-Costa, JA Santos Miranda, and JC Antoranz. Assesment of cancer immunotherapy outcome in terms of the immune response time features. Math Med Biol, 24:287-300, 2007.

D Dingli, MD Cascino, K Josic, SJ Russell, and Z Bajzer. Mathematical modeling of cancer radiovirotherapy. Mathematical Biosciences, 199:55-78, 2006.

LG dePillis, W Gu, and AE Radunskaya. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. Journal of Theoretical Biology, 238:841-862, 2006.

H Enderling, MAJ Chaplain, ARA Anderson, and J Vaidya. A mathematical model of breast cancer development, local treatment and recurrence. Journal of Theoretical Biology, 246:245-259, 2007.

VS Khoo. Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy. Clinical Oncology, 17:560-571, 2005.

TL Whiteside. Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: implications for immunotherapy. Vaccine, 20:A46-A51, 2002.

TL Whiteside. Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention. Seminars in Cancer Biology, 16:3-15, 2006.

S Sundstrom, R Bremnes, U Aasebo, S Aamdal, R Htlevoll, P Brunsvig, DC Johannessen, O Klepp, PM Fayers, and Kaasa S. Hypofractioned palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial. Journal of Clinical Oncology, 22:801-810, 2004.

GG Steel. Basic Clinical Radiobiology for Radiation Oncologists. Edward Arnold Publishers, London, 1993.

D Rades and S Lang. Prognostic value of haemoglobin levels during concurrent radio-chemotherapy in the treatment of oesophageal cancer. Clinical Oncology, 18:139-144, 2006.

WH Press, SA Teukolsky, WT Vetterling, and BP Flannery. Numerical Recipes in C, The Art of Scientific Computing. Cambrige, Cambrige University Press, 1992.

H Enderling, RA Alexander, and AJ Mark. Mathematical modelling of radiotherapy strategies for early breast cancer. Journal of Theoretical Biology, 241:158-171, 2006.

Published

2014-10-28

How to Cite

Sotolongo Grau, O., Rodríguez Pérez, D., Antoranz, J. C., Gaggero Sager, L. M., & Sotolongo Costa, O. (2014). Radiotherapy and the role of the immune system. Nova Scientia, 4(8), 13–25. https://doi.org/10.21640/ns.v4i8.165

Issue

Section

Natural Sciences and Engineering

Metrics